Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Willowbrook › NPI 1275049066
Physician

Pharaon, Ayman

Pharaon, Ayman was paid $71K by Medicaid between May 2022 and Feb 2023, across 23 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.

33Billing provider infoPHARAON, AYMAN
WILLOWBROOK, IL 60527
33aNPI1275049066assigned 12/16/2017
33bProvider typePediatrics Physician
28Total paid$71K
24GClaims1,576
24DCodes billed23
24AFirst – last monthMay 2022 – Feb 2023
Compared with peers

Next to other Pediatrics Physician providers in Illinois

Rank by total paid#836 of 1,805
Median peer was paid$55K
This provider vs. median1.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20221,536$70K
202340$1K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 30% 459 426 $21K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 17% 37 37 $12K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 9.0% 142 132 $6K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 5.7% 53 49 $4K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4.5% 42 35 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 4.1% 33 33 $3K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 4.0% 34 32 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2.6% 117 116 $2K
87581 2.5% 40 40 $2K
87486 2.5% 40 40 $2K
90686 2.4% 106 88 $2K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2.4% 75 74 $2K
11 more codes
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.0% 20 $1K
90744 2.0% 93 $1K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1.9% 17 $1K
99000 1.6% 50 $1K
90633 1.3% 57 $945.01
90713 1.2% 50 $831.35
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.1% 32 $813.80
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 20 $479.95
90716 <1% 22 $364.31
90651 <1% 18 $300.78
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 0% 19 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.